Previous 10 | Next 10 |
Shares of iBio (NYSEMKT: IBIO) climbed on Friday after the biotech announced plans to develop an intriguing second-generation vaccine candidate for COVID-19. By the close of trading, iBio's stock price was up 16.7% after rising as much as 41.3% earlier in the day. iBio's exp...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ibio (NYSEAMERICAN: IBIO ) stock is soaring higher on Friday after announcing a next-generation vaccine program to treat the novel coronavirus. Source: Shutterstock This new program has it developing IBIO-202...
ChemoCentryx hurt by a series of downgradesLate yesterday, ChemoCentryx (CCXI) announced its narrow win at the FDA’s expert panel meeting on the potential approval for avacopan in the treatment of vasculitis associated with antineutrophil cytoplasmic autoantibody ((ANCA)).At least...
iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Da...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and get ready to take a break and unwind over the weekend. But don’t take off the suit and tie just yet! There’s still got one more busy day of trading to get through and we’re here to help...
BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an update on its IBIO-201 program and reported on its progress in developin...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ibio (NYSEAMERICAN: IBIO ) stock is on the rise Wednesday after announcing an end to its legal battle with Fraunhofer USA . Source: Shutterstock The end of the lawsuit comes as the two companies have reached...
Gainers: Regional Health Properties (RHE) +71%, Chiasma CHMA +45%, Nemaura Medical (NMRD) +35%, Athenex (ATNX) +40%, iBio (IBIO) +29%.Losers: Cocrystal Pharma COCP -32%, Esperion Therapeutics ESPR -26%, Adamis Pharmaceuticals (ADMP) ...
Chiasma (CHMA) +39% on Q1 results.Athenex (ATNX) +31% on Kuur Therapeutics acquisition.Ault Global Holdings (DPW) +30% on preliminary Q1 results.iBio (IBIO) +26% after resolving Fraunhofer USA lawsuitBig 5 Sporting Goods Corporation (BGFV) +22% on Q1 results.DAVIDsTEA...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the halfway point of the week, investors! Here at InvestorPlace , we’re starting the day off like we always do with a look at the biggest pre-market stock movers. Join us as we list out t...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...